Peer-reviewed veterinary case report
Dogs with blastomycosis treated using high-flow nasal oxygen therapy
By Tarosky, Melanie et al.·Published in Frontiers in veterinary science·2024·Department of Veterinary Clinical Medicine, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Case series of dogs with blastomycosis managed with high-flow nasal oxygen therapy (2019-2023): 19 cases.
- Species:
- dog
Plain-English summary
Nineteen dogs with suspected or confirmed blastomycosis, a serious fungal infection, were treated with high-flow nasal oxygen therapy (HFNOT) at a veterinary hospital. While some dogs initially received standard oxygen therapy, they were later switched to HFNOT. Unfortunately, only one dog survived and was discharged, while twelve were euthanized due to worsening conditions, and six died during treatment. This case series highlights the challenges of treating severe blastomycosis in dogs and suggests that the prognosis for these cases is often poor.
People also search for: dog blastomycosis treatment · high-flow oxygen therapy for dogs · symptoms of blastomycosis in dogs
Abstract
OBJECTIVE: To describe the clinical presentation, progression, treatment, and outcome of dogs with blastomycosis treated with high-flow nasal oxygen therapy (HFNOT). DESIGN: Retrospective case review. SETTING: University veterinary teaching hospital. ANIMALS: Nineteen client-owned dogs with strongly suspected or confirmed blastomycosis treated with HFNOT. MEASUREMENTS AND MAIN RESULTS: The medical records of dogs with strongly suspected or confirmed blastomycosis between October 2019 and May 2023 that received HFNOT were evaluated. Nineteen dogs were included. Nine dogs were started directly on high-flow nasal oxygen therapy. The remaining 10 dogs first received traditional oxygen therapy and were then transitioned to HFNOT 3-142 h later. Of the 19 dogs, 1 survived to discharge from hospital, 12 were euthanized due to progression of disease, and 6 died during the hospitalization period. CONCLUSIONS AND CLINICAL IMPORTANCE: The prognosis for survival of dogs with severe blastomycosis requiring therapy beyond traditional oxygen methods was poor to grave in this population. This is the first known documented report of HFNOT use in dogs with confirmed or suspected blastomycosis.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/38903690/